NCT06999954
- Conditions
- Bone Marrow Diseases, Bone Marrow Failure Disorders, Cognitive Delay, Mild, +54 more
- Locations
-
- Shwachman-Diamond Syndrome Alliance Inc. Woburn, Massachusetts, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,146 public trials
2,034 recruiting studies
Lymphoproliferative Disorders trial results
NCT06999031
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
NCT04898647
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- CHU Amiens Amiens, France
NCT06961669
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +25 more
- Locations
-
- The First Affiliated Hospital of University of Science and Technology of China Hefei, China
NCT03937544
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- UKM Medical Centre Bandar Tun Razak, Kuala Lumpur, Malaysia
NCT06935162
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Recruiting
TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL
NCT06014073
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Biotherapeutic Department, Chinese PLA General Hospital Beijing, China
- EdiGene Inc Beijing, China
- School of Life Sciences, Peking University Beijing, China
NCT06323525
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China
- Biotherapeutic Department of Chinese PLA General Hospital Beijing, China
- School of Life Sciences, Peking University Beijing, China
Recruiting
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1
NCT06718244
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
NCT06228794
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China